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A BST R AC T   
 
Aim: Differentiation of thyroid nodules, either as benign or malignant, is a real diagnostic challenge. 
Inflammation has an important role in development of the malignancy. Therefore, inflammatory markers are 
associated with malignant thyroid nodules. Platelet /lymphocyte ratio (PLR) is also one of the novel 
inflammatory indices derived from hemogram tests. We hypothesized whether PLR was associated with 
malignant thyroid nodules. For this purpose, we compared PLR levels of the patients with benign thyroid 
nodules to the PLR of the subjects with malignant nodules. 
Methods: The subjects who visited outpatient internal medicine clinics of our institution with a diagnosis of 
thyroid nodule were enrolled to the present retrospective study. According to the examination of the fine needle 
aspiration cytology (FNAC) specimen of the nodules, patients grouped into benign or malignant nodule groups. 
PLR of groups were compared.  
Results: Median PLR values of the benign and malignant thyroid nodule groups were 106 (48-432) % and 119 
(48-365) %, respectively (p=0.001). PLR value higher than 106% has 69% sensitivity and 51% specificity in 
detecting malignant nodules (AUC: 0.59, p=0.001, 95% CI: 0.54-0.65). PLR was positively correlated with 
TSH level (r=0.10, p=0.34).  
Conclusion: We suggest that elevated PLR could be an additional tool to differentiate malignant thyroid 
nodules from benign ones in supportive of sonography, scintigraphy and cytology.  
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Introduction 
Differentiation of thyroid nodules, either as 
benign or malignant, is a real diagnostic 
challenge. Since a considerable amount of 
thyroid nodules are malignant, differentiation 
of these nodules is crucial. Nodules may 
develop in thyroid gland especially in iodine 
deficient areas of the world and its prevalence 
in women may reach up to 5% [1]. Detection 
rate of thyroid nodules by ultrasound scanning 
is a bit higher as 20% [2].  
Inflammation has an important role in 
development of the malignancy [3]. Therefore, 
inflammatory markers are associated with 
malignant thyroid nodules. For instance, c-
reactive protein (CRP) and novel inflammatory 
markers, such as, mean platelet volume, red cell 
distribution width and neutrophil/lymphocyte 
ratio are elevated in malignant thyroid nodules 
[4-7].  
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Platelet /lymphocyte ratio (PLR) is also one of 
the novel inflammatory indices derived from 
hemogram tests. It has substantial diagnostic 
and prognostic value in certain conditions. PLR 
has been correlated with glycated hemoglobin 
(HbA1c) levels in subjects with type 2 diabetes 
mellitus [8]. Moreover, authors suggested PLR 
as a prognostic factor of survival in colorectal 
cancer patients [9].  
As other cancer types and type 2 diabetes 
mellitus, malignant thyroid nodules are 
associated with inflammation. Therefore, we 
hypothesized whether PLR was associated with 
malignant thyroid nodules. For this purpose, we 
compared PLR levels of the patients with 
benign thyroid nodules to the PLR of the 
subjects with malignant nodules.  
 
Materials and methods 
The subjects who visited outpatient internal 
medicine clinics of our institution between May 
2018 and December 2020 with a diagnosis of 
thyroid nodule were enrolled to the present 
retrospective study. Ethical approval obtained 
from institutional ethics committee (approval 
number: 2021-26). The study was conducted in 
accordance with the principles of the 
Declaration of Helsinki. All patients and the 
institution were informed about the study and 
their written consents were obtained. 
According to the cytological examination of the 
fine needle aspiration biopsy (FNAB) specimen 
of the nodules, patients grouped into benign or 
malignant nodule groups.  
Age, sex, thyroid stimulating hormone (TSH), 
white blood cell count (WBC), hemoglobin 
(Hb), hematocrit (Htc), lymphocyte count 
(lym), platelet count (PLT) were obtained from 
the laboratory tests of the participants that held 
before FNAB. Exclusion criteria were as 
follows; inflammatory conditions including 
thyroiditis, recent infection, type 2 diabetes 
mellitus, cancer, hematologic conditions that 
may affect platelet count, use of medicines that 
may interfere with hematopoiesis or 
thrombocyte functions (i.e. corticosteroids, 
acetyl salicylate). Hemogram tests were held 
with Abbott Cell-Dyn 3700 automatic analyzer 
device (Abbott Laboratories, Abbott Park, IL, 
USA). TSH assay was done with original kits 
of the manufacturer in Abbott Architect 
i2000SR device (Abbott Laboratories, Abbott 
Park, IL, USA).  
Statistical analysis conducted by SPSS software 
(SPSS15.0; SPSS Inc., Chicago, IL, USA). 
Fitness of the measurable variables to normal 
distribution was evaluated by Kolmogorov-
Smirnov test. Variables with normal 
distribution were compared with student t test 
and expressed as mean ± Standard Deviation.  
Variables without normal distribution were 
compared with Mann Whitney u test and 
expressed as median (minimum-maximum). 
Comparison of the frequency data was held 
with X2 test and these data were expressed as 
percentage. Significance level is considered as 




After application of exclusion criteria, 
remaining 443 patients were enrolled to the 
study. Benign thyroid nodule group was 
consisted of 207, while malignant thyroid 
nodule group was consisted of 236 subjects.  
Mean ages of the benign and malignant thyroid 
nodule groups were 43.1 ± 7.4 years and 44.6 ± 
11.6 years, respectively (p=0.12).  
Forty nine (24%) of the subjects were male and 
158 (76%) were female in benign thyroid 
nodule group while 55 (23%) were male and 
181 (77%) were female in malignant thyroid 
nodule group. Gender was not statistically 
different among study groups, either (p=0.93).   
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The Hb (p=0.49), Htc (p=0.07), WBC 
(p=0.08), Plt (p=0.76) and TSH (p=0.16) of the 
benign and malignant thyroid nodule groups 
were not statistically different.   
Median PLR values of the benign and 
malignant thyroid nodule groups were 106 (48-
432) % and 119 (48-365) %, respectively. PLR 
value of the malignant thyroid nodule group 
was significantly higher than that of the benign 
thyroid nodule group (p=0.001).  
A ROC analysis revealed that a PLR value 
higher than 106% has 69% sensitivity and 51% 
specificity in detecting malignant nodules 
(AUC: 0.59, p=0.001, 95% CI: 0.54-0.65). 
Figure 1 shows the ROC curve of PLR in 
detecting malignant thyroid nodules.  
In Pearson’s correlation analysis, PLR was 
positively correlated with TSH level (r=0.10, 
p=0.34). Figure 2 shows the correlation 











































Present study demonstrated that PLR of the 
subjects with malignant thyroid nodule is 
significantly elevated compared to the PLR of 
the subjects with benign thyroid nodule. 
Another important outcome of present study is 
moderate sensitivity and specificity of the PLR 
in detecting malignant nodules in thyroid gland. 
Finally, significant positive correlation between 
TSH and PLR was revealed by present work.  
Recent studies pointed out the diagnostic and 
prognostic role of PLR in various inflammatory 
conditions. Atak et al reported that PLR was 
associated with type 2 diabetes mellitus and 
correlated with HbA1c [8]. PLR levels of the 
subjects with lower extremity deep venous 
thrombosis were significantly higher than the 
PLR levels of the subjects without thrombosis 
[10]. Moreover, patients with Covid-19 have 
increased PLR levels compared to the healthy 
controls [11]. In addition, elevated PLR was 
suggested to be a predictor of early mechanical 
ventilation requirement in subjects with Covid-
 
Figure 1. The ROC curve of PLR in detecting 




Figure 2. Correlation between TSH and PLR. 
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19 [12]. Both, type 2 diabetes mellitus, venous 
thrombosis and Covid-19 infection are 
inflammatory conditions as malignant thyroid 
nodules. Therefore, the findings of present 
study, which revealed elevated PLR levels in 
patients with malignant thyroid nodules, are 
consisted with literature.   
The role of inflammation in cancer 
development is pivotal [13,14]. PLR is a novel 
inflammatory marker. Therefore, cancer is also 
associated with increased PLR values. A study 
from Poland reported that PLR was correlated 
with survival in patients with endometrium 
cancer [15]. High PLR levels were correlated 
with worse overall survival in oral squamous 
cell carcinoma patients [16]. Preoperative PLR 
level has been proposed as an independent 
prognostic factor of survival in rectal cancer 
[17]. Authors reported that PLR level in 
pretreatment period could be a prognostic index 
in patients with non-small cell lung cancer [18]. 
The PLR of the patients with recurrent ovarian 
cancer are higher than the PLR of healthy 
subjects [19]. Malignancy attracts 
inflammatory cells and causes an increase in 
circulating inflammatory mediators. Malignant 
thyroid nodules are also causing such 
inflammatory burden. As shown in present 
study, PLR levels of these subjects are 
increased compared to the PLR levels of the 
patients with benign thyroid nodules.  
Thyroid nodules are associated with 
inflammation. Authors found that the 
prevalence of thyroid nodules is higher in 
subjects with hyperhomocysteinemia, another 
condition that precedes inflammation [20]. Sit 
et al reported that mean platelet volume and 
neutrophil/lymphocyte ratios were predictors of 
malignancy in thyroid nodules [6,7]. Moreover, 
erythrocyte distribution width has been 
introduced as a predictor of malignant thyroid 
nodules in patients with nodular goiter [5]. 
Both, mean platelet volume, 
neutrophil/lymphocyte ratio and erythrocyte 
distribution width are inflammatory markers of 
hemogram tests, as the PLR. Therefore, similar 
elevation in PLR noticed in malignant nodules 
compared to benign nodules in present study.  
Sonographic characteristics for suspicious 
malignancy in thyroid nodules include 
speculated edges, vertical shape, micro-
calcification and hypoechogenicity, which all 
have diagnostic sensitivity less than 50% [21]. 
Another tool for differentiating malignant and 
benign nodules is scintigraphy. Cold nodules in 
thyroid scintigraphy images are more likely to 
be malignant. However, nearly 3 of every 4 cold 
nodules is not malignant and malignancy 
detected in cytology of the 6% of hot nodules 
[22]. Gold standard method of the diagnosis of 
thyroid nodules as benign or malignant is fine 
needle aspiration cytology (FNAC), however, 
false negative and false positive results of 
FNAC have been reported around 10% [23]. 
Therefore, elevated PLR in malignant thyroid 
nodules compared to benign nodules could be a 
useful adjunctive test in discrimination of these 
nodules.   
Relatively small study population and 
retrospective design of the work are two main 
limitations of our study. However, to the bet of 
our knowledge, this is the first study in 
literature reported elevated PLR levels in 
patients with malignant thyroid nodules.  
In conclusion, we suggest that elevated PLR 
could be an additional tool to differentiate 
malignant thyroid nodules from benign ones in 
supportive of sonography, scintigraphy and 
cytology.  
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